Current Topics in Medicinal Chemistry is a forum for the review of areas of keen and topical interest to medicinal chemists and others in the allied disciplines. Each issue is solely devoted to a specific topic, containing six to nine reviews, which provide the reader a comprehensive survey of that area. A Guest Editor who is an expert in the topic under review, will assemble each issue. The scope of Current Topics in Medicinal Chemistry will cover all areas of medicinal chemistry, including current developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, compound diversity measurements, drug absorption, drug distribution, metabolism, new and emerging drug targets, natural products, pharmacogenomics, and structure-activity relationships. Medicinal chemistry is a rapidly maturing discipline. The study of how structure and function are related is absolutely essential to understanding the molecular basis of life. Current Topics in Medicinal Chemistry aims to contribute to the growth of scientific knowledge and insight, and facilitate the discovery and development of new therapeutic agents to treat debilitating human disorders. The journal is essential for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important advances.
Jia Zhou Chemical Biology Program Department of Pharmacology and Toxicology University of Texas Medical Branch Galveston, TX (USA) Biography
Biography of Jia Zhou
Dr. Jia Zhou is currently a tenured Professor in the Chemical Biology Program at University of Texas Medical Branch (UTMB), USA. He was educated with a PhD degree and trained as a postdoctoral research fellow from Nankai University, University of Virginia, and Georgetown University Medical Center, respectively. He has over 20 years of research experience in medicinal chemistry, drug discovery and development including 7 years of industrial experience in pharmaceuticals. Dr. Zhou’s research interest is drug discovery and development of novel small molecules as potential therapeutics for the treatment of central nervous system (CNS) disorders, cancer, inflammation, and infectious diseases. He is an author of more than 190 papers, 7 book chapters and an inventor of 26 patents. He is also a National Academy of Inventors (NAI) Fellow.